Skip to main content

A multicenter, international, open-label, safety study of ND0612, a solution of levodopa/carbidopa delivered via a pump system as a continuous subcutaneous infusion in subjects with advanced Parkinson's Disease (UBeyoNDU)

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Movement Disorders

Awarded By

NeuroDerm, Ltd

Start Date

June 15, 2017

End Date

February 8, 2018
 

Administered By

Neurology, Movement Disorders

Awarded By

NeuroDerm, Ltd

Start Date

June 15, 2017

End Date

February 8, 2018